Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $7.81 | Prev. Close $7.86 | Circuit Range N/A |
Day Range $7.73 - $8.32 | Year Range $5.01 - $10.64 | Volume 1,91,570 |
Average Traded $8.03 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
15-Jan-26 | $8.06 | $7.77 | -5.12% |
14-Jan-26 | $8.48 | $8.19 | -5.66% |
13-Jan-26 | $7.90 | $8.68 | +11.86% |
12-Jan-26 | $7.31 | $7.76 | +6.81% |
09-Jan-26 | $7.43 | $7.26 | -1.09% |
08-Jan-26 | $7.45 | $7.34 | -3.61% |
07-Jan-26 | $7.48 | $7.62 | +2.56% |